Cyclin-Dependent Kinase (CDK) Inhibitors Therapeutics Pipeline Projects Vast Growth Ahead     |    CAD Software Market to Reach $11,097 Million by 2023     |    Friedreich’s Ataxia (FRDA) Therapeutics Pipeline to Receive Various Drug Designations from the USFDA and EMA in the Coming Years
P&S Market Research - A market research firm

Blood Group Typing Market

P&S Market Research-Blood Group Typing Market report

Global Blood Group Typing Market Size, Share, Development, Growth and Demand Forecast to 2023

Delivery : 24-72 Working Hours
Report Code: LS11088
Available Format: pdf
Category : Biotechnology

Market Overview

Blood group typing is a procedure of determining what specific type of blood a person has, which depends on the presence of antigens on the red blood cells. It is done in organ donation process, to safely donate or receive a blood transfusion and to determine whether Rh factor is present on the surface of the red blood cell. Blood group typing is very important during pregnancy as it can prevent severe anaemia in the new born. There are various techniques and methods to detect the blood group. The global blood group typing market has witnessed significant growth due to the advancement in technology which has improved detection methods.

The global blood group typing market is categorized on the basis of the product and service offerings; techniques used; type of tests; and its end users. Based on product and services, the global market is segmented into consumables, instruments and services. Consumable, which includes blood bank saline, anti-human globulin reagents, antisera reagents and red blood cells reagents, held largest share in the global blood typing market in 2016. It has major contribution towards the growth of the global group typing market as compared to other segments. The major factor driving this growth are increasing rate of blood donation and major surgical procedures like organ transplantation.

Massively parallel sequencing, polymerase chain reaction (PCR) based and microarray techniques, assay-based techniques and other techniques are used for blood group typing. Among different techniques, the global PCR-based and microarray blood group typing market is expected to witness the fastest growth during the forecast period (2017 – 2023). Increase in R&D activities on understanding the molecular basis of blood and antibody-antigen interactions, and rise in chronic diseases has resulted in increase in the use of PCR-based and microarray techniques.

Blood group typing can be done via various tests namely, antigen typing, cross-matching tests, antibody screening, human leukocyte antigen (HLA) typing and ABO blood tests. Among the different blood group typing tests, antibody screening is expected to witness the fastest growth in the global market during the forecast period. Rising demand for early disease diagnosis and increase in chronic disorder cases is causing the growth in the usage of the antibody screening test for blood group typing.

Globally, the demand for blood group typing products and services was largest in hospitals due to the increasing awareness regarding the importance of blood donations and growth in the requirements of blood for surgical treatments. Other key end users in the global blood group typing market are clinical laboratories and blood banks.

Market Dynamics

Growth Drivers

The global blood group typing market is expected to grow significantly during the forecast period. The major driving force behind this growth are the increase in the use of blood group typing in forensic science; need for grouping of the blood during pregnancy and prenatal testing; growth in the number of road accidents and trauma cases that requires blood transfusion; increase in the demand of blood and blood products; and rise in blood donation. Blood group typing is very crucial for the detection of hemolytic disease of the newborn (HDN) in pregnant women which eventually stimulates the usage of blood group typing, hence causing the growth of the global market.


Regulatory standards for the blood transfusion are stringent as it is a very crucial process. Stringent regulatory requirements hinder the growth of the global blood group typing market. Other key factor restraining the growth of the global market is lack of trained and skilled professionals which can cause misleading transfusion.

Opportunities and Trends

The development of novel molecular diagnostic tools which helps in reliable and rapid identification of blood groups in large samples is expected to provide abundant opportunities to the market players.

The rise in the number of blood donations is the key trend witnessed in the global blood group typing market. Also, the technology advancements like quantum dots (QDs) and magnetic beads in assays that improve identification and enhance clinical safety of blood transfusion have also been witnessed globally.

Insights by Geography

North America held the largest share in the global blood group typing market in 2016, followed by Europe. It was the prominent market for the blood group typing products and services. The reasons of the dominance of North America is the presence of different reimbursement schemes for several surgeries and prevalence of chronic diseases. Asia-Pacific blood group typing market is expected to witness the fastest growth during the forecast period with the growth centered at China, Japan, and India.

Competitive Landscape

They key players in the global blood group typing market are Bio-Rad Laboratories, Inc., Immucor, Inc., Quotient Limited, BAG Health Care GmbH, DAY medical SA, Grifols S.A., Ortho Clinical Diagnostics, Inc., Novacyt Group, DIAGAST, AXO Science, and Agena Bioscience, Inc.

In October 2016, Bio-Rad Laboratories, Inc., a manufacturer of life sciences and clinical diagnostic products, received the U.S. Food and Drug Administration (FDA) approval for its IH-1000 blood instrument.

In May 2014, Immucor’s PreciseType HEA Test received FDA approval to be used for screening blood donors for sickle cell trait (SCT). The PreciseType HEA test is the FDA-approved molecular assay designed to provide blood banks and clinicians with the detailed genetic matching information that they need to reduce the risk of alloimmunization and serious haemolytic reactions, which is especially problematic for patients receiving frequent blood transfusions.

By Product & Service

  • Consumables
    • Antisera reagents,
    • Anti-human globulin reagents,
    • Red blood cells reagents,
    • Blood bank saline.
  • Instruments
  • Services

By Technique

  • PCR-based and microarray techniques
  • Assay-based techniques
  • Massively parallel sequencing techniques
  • Other techniques

By Test Type

  • Antibody screening
  • HLA typing
  • Cross-matching tests
  • ABO blood tests
  • Antigen typing

By End User

  • Hospitals
  • Blood banks
  • Clinical laboratories
  • Other end users

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • South Africa
    • Rest of MEA

Place An Order

Single User License

Single User License authorizes access of the publication to single user, i.e. the buyer of the report.

Group License

Group License authorizes access of the publication upto 5 users.

Enterprise License

Enterprise License provides right to distribute copies of the publication across the organization and its subsidiaries.


Pre-Purchase Enquiry


Contact Us

  • U.S. Center : 347 5th Ave. #1402- 210 New York City, NY 10016 United States
  • Asian Center : B-28, Sector 1, Noida, U.P. - 201301 India.

Secure Online Payments

  • Payment